Patents by Inventor Olga Genilloud

Olga Genilloud has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10414745
    Abstract: The present invention relates to compounds of general formula (I) wherein R1-R8 take various meanings, pharmaceutical compositions containing them and their use in medicine, particularly for the treatment and/or prophylaxis of cancer.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: September 17, 2019
    Assignee: FUNDACIÓN MEDINA. CENTRO DE EXCELENCIA EN INVESTIGACIÓN DE MEDICAMENTOS INNOVADORES EN ANDALUCÍA
    Inventors: Nuria De Pedro Montejo, Victor Gonzalez Menendez, Gloria Crespo Sueiro, Ignacio Perez-Victoria Moreno De Barreda, Bastien Cautain, Maria Francisca Vicente Perez, Jose Fernando Reyes Benitez, Olga Genilloud Rodriguez, Carmen Grinan Lison, Juan Antonio Marchal Corrales
  • Publication number: 20180148427
    Abstract: The present invention relates to compounds of general formula (I) wherein R1-R8 take various meanings, pharmaceutical compositions containing them and their use in medicine, particularly for the treatment and/or prophylaxis of cancer.
    Type: Application
    Filed: April 29, 2016
    Publication date: May 31, 2018
    Applicant: FUNDACION MEDINA CENTRO DE EXCELENCIA DE MEDICAMENTOS INNOVA
    Inventors: Nuria DE PEDRO MONTEJO, Victor GONZALEZ MENENDEZ, Gloria CRESPO SUEIRO, Ignacio PEREZ-VICTORIA MORENO DE BARREDA, Bastien CAUTAIN, Maria Francisca VICENTE PEREZ, Jose Fernando REYES BENITEZ, Olga GENILLOUD RODRIGUEZ, Carmen GRINAN LISON, Juan Antonio MARCHAL CORRALES
  • Publication number: 20160185717
    Abstract: The present invention relates to compounds of general formula (I) wherein R1, R2, R3 and take various meanings, pharmaceutical compositions containing them and their use in medicine, particularly for the treatment and/or prophylaxis of a bacterial infection disease.
    Type: Application
    Filed: June 30, 2014
    Publication date: June 30, 2016
    Inventors: Olga GENILLOUD RODRÍGUEZ, José Rubén TORMO BELTRÁN, José Fernando REYES BENÍTEZ, Noureddine EL AOUAD, Maria Francisca VICENTE PEREZ, Mercedes DE LA CRUZ MORENO, Gerald Fremont BILLS, Victor Manuel GONZÁLEZ MENÉNDEZ, Maria Cåndida TEIRO DE AGUIAR
  • Patent number: 9126983
    Abstract: The present invention relates to novel compounds of formulae (I) and (II) and pharmaceutically acceptable salts thereof that are useful in the treatment and/or prevention of human and animal bacterial infections and associated diseases and conditions; compositions containing such compounds; derivation of such compounds by fermentation and isolation, partial synthesis and total synthesis; methods of inhibiting bacterial growth; methods of treating, preventing or controlling bacterial infection; biologically pure cultures of bacterial strains from which such compounds may be produced; and processes for preparing compositions containing such compounds.
    Type: Grant
    Filed: December 17, 2010
    Date of Patent: September 8, 2015
    Assignees: Merck Sharp & Dohme Corp., Merck Sharp & Dohme de Espana SA
    Inventors: Sheo Singh, Jon D. Polishook, Deborah L. Zink, Olga Genilloud, Michael Goetz, Francisca Vicente, David Brian Olsen, Scott Knoble Smith
  • Publication number: 20130005673
    Abstract: The present invention relates to novel compounds of formulae (I) and (II) and pharmaceutically acceptable salts thereof that are useful in the treatment and/or prevention of human and animal bacterial infections and associated diseases and conditions; compositions containing such compounds; derivation of such compounds by fermentation and isolation, partial synthesis and total synthesis; methods of inhibiting bacterial growth; methods of treating, preventing or controlling bacterial infection; biologically pure cultures of bacterial strains from which such compounds may be produced; and processes for preparing compositions containing such compounds.
    Type: Application
    Filed: December 17, 2010
    Publication date: January 3, 2013
    Inventors: Sheo Singh, Jon D. Polishook, Deborah L. Zink, Olga Genilloud, Michael Goetz, Francisca Vicente, David Brian Olsen, Scott Knoble Smith
  • Patent number: 7807445
    Abstract: Fermentation of a nutrient medium with a eubacterium Streptomyces sp. yields a novel antibacterial compound of structural formula (I).
    Type: Grant
    Filed: May 20, 2005
    Date of Patent: October 5, 2010
    Assignees: Merck Sharp and Dohme de Espana, S.A., Merck Sharp & Dohme Corp.
    Inventors: Angela Basilio, Olga Genilloud, Hiranthi Jayasuriya, Ignacio Gonzalez, Sheo B. Singh, Oscar Salazar, Jun Wang
  • Patent number: 7745644
    Abstract: Fermentation of a nutrient medium with a eubacterium Streptomyces sp. yields a novel antibacterial compound of structure (I).
    Type: Grant
    Filed: July 20, 2004
    Date of Patent: June 29, 2010
    Assignees: Merck Sharp & Dohme Corp., Merck Sharp and Dohme de Espana, S.A.
    Inventors: Angela Basilio, Olga Genilloud, Pilar Hernandez, Sheo Bux Singh, Jose Rueben Tormo, Jun Wang
  • Publication number: 20100144879
    Abstract: Fermentation of a nutrient medium with a eubacterium Streptomyces sp. yields a novel antibacterial compound of structural formula (I).
    Type: Application
    Filed: May 20, 2005
    Publication date: June 10, 2010
    Inventors: Angela Basilio, Olga Genilloud, Hiranthi Jayasuriya, Ignacio Gonzalez, Sheo B. Singh, Oscar Salazar, Jun Wang
  • Publication number: 20080306139
    Abstract: Fermentation of a nutrient medium with a eubacterium Streptomyces sp. yields a novel antibacterial compound of structure (I).
    Type: Application
    Filed: July 20, 2004
    Publication date: December 11, 2008
    Inventors: Angela Basilio, Olga Genilloud, Pilar Hernandez, Sheo Bux Singh, Jose Rueben Tormo, Jun Wang
  • Patent number: 6395743
    Abstract: Compounds useful in the inhibition of HIV integrase, the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines are described. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described. The culture Actinoplanes sp. MA7220 (ATCC 202188) is also disclosed, as well as processes for making compounds of the present invention employing the culture.
    Type: Grant
    Filed: October 12, 2000
    Date of Patent: May 28, 2002
    Assignee: Merck & Co., Inc.
    Inventors: Brian Heimbuch, Sheo Singh, Deborah L. Zink, Magda Gagliardi, Olga Genilloud, Ana Teran